Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of VELCADE in Combination With Rituximab in Patients With Relapsed or Progressed Non Hodgkin's Follicular Lymphoma

NCT01830465 is registered in ClinicalTrials.gov with Gruppo Italiano Studio Linfomi as lead sponsor.

NCT NCT01830465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of VELCADE in Combination With Rituximab in Patients With Relapsed or Progressed Non Hodgkin's Follicular Lymphoma
Lead sponsor
Gruppo Italiano Studio Linfomi
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
May 31, 2011
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non hodgkin's follicular lymphoma